Development of 5D3-DM1: A novel anti-prostate-specific membrane antigen antibody-drug conjugate for PSMA-positive prostate cancer therapy

CT Huang, X Guo, C Barinka, SE Lupold… - Molecular …, 2020 - ACS Publications
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy.

CT Huang, X Guo, C Bařinka, SE Lupold… - Molecular …, 2020 - europepmc.org
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A novel anti-prostate-specific membrane antigen antibody-drug conjugate for PSMA-positive prostate cancer therapy

CT Huang, MG Pomper, V Raman, D Artemov… - Molecular …, 2020 - elibrary.ru
This study was mainly supported by the Emerson Collective Cancer Research Fund (2018
Emerson Collective 128821). This work was partially supported by the DOD (W81XWH-16-1 …

[HTML][HTML] Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy

CT Huang, X Guo, C Bařinka, SE Lupold… - Molecular …, 2020 - ncbi.nlm.nih.gov
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy

CT Huang, X Guo, C Bařinka… - Molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy

CT Huang, X Guo, C Barinka, SE Lupold… - Molecular …, 2020 - hero.epa.gov
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A novel anti-prostate-specific membrane antigen antibody-drug conjugate for PSMA-positive prostate cancer therapy

CT Huang, X Guo, C Bařinka… - Molecular …, 2020 - utsouthwestern.elsevierpure.com
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A novel anti-prostate-specific membrane antigen antibody-drug conjugate for PSMA-positive prostate cancer therapy

CT Huang, X Guo, C Bařinka… - Molecular …, 2020 - pure.johnshopkins.edu
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …

Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy.

CT Huang, X Guo, C Bařinka, SE Lupold… - Molecular …, 2020 - europepmc.org
Prostate cancer (PC) is a potentially high-risk disease and the most common cancer in
American men. It is a leading cause of cancer-related deaths in men in the US, second only …